Cargando…

Efficacy of corticosteroid treatment for hospitalized patients with severe COVID-19: a multicentre study

OBJECTIVE: To assess the efficacy of corticosteroids in patients with coronavirus disease 2019 (COVID-19). METHODS: A multicentre observational study was performed from 22 February through 30 June 2020. We included consecutive adult patients with severe COVID-19, defined as respiratory rate ≥30 brea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bartoletti, Michele, Marconi, Lorenzo, Scudeller, Luigia, Pancaldi, Livia, Tedeschi, Sara, Giannella, Maddalena, Rinaldi, Matteo, Bussini, Linda, Valentini, Ilaria, Ferravante, Anna Filomena, Potalivo, Antonella, Marchionni, Elisa, Fornaro, Giacomo, Pascale, Renato, Pasquini, Zeno, Puoti, Massimo, Merli, Marco, Barchiesi, Francesco, Volpato, Francesca, Rubin, Arianna, Saracino, Annalisa, Tonetti, Tommaso, Gaibani, Paolo, Ranieri, Vito Marco, Viale, Pierluigi, Cristini, Francesco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7506332/ https://www.ncbi.nlm.nih.gov/pubmed/32971254 http://dx.doi.org/10.1016/j.cmi.2020.09.014

Ejemplares similares

Development and validation of a prediction model for severe respiratory failure in hospitalized patients with SARS-CoV-2 infection: a multicentre cohort study (PREDI-CO study)
por: Bartoletti, Michele, et al.
Publicado: (2020)

Corrigendum to: “Development and validation of a prediction model for severe respiratory failure in hospitalized patients with SARS-CoV-2 infection: a multicentre cohort study (PREDI-CO study)” Clinical Microbiology and Infection 26 (2020) 1545–1553
por: Bartoletti, Michele, et al.
Publicado: (2023)

Cefiderocol treatment for carbapenem-resistant Acinetobacter baumannii infection in the ICU during the COVID-19 pandemic: a multicentre cohort study
por: Pascale, Renato, et al.
Publicado: (2021)

Klebsiella pneumoniae Bloodstream Infection: Epidemiology and Impact of Inappropriate Empirical Therapy
por: Girometti, Nicolò, et al.
Publicado: (2014)

Carbapenem-resistant bacteria in an intensive care unit during the coronavirus disease 2019 (COVID-19) pandemic: A multicenter before-and-after cross-sectional study
por: Pascale, Renato, et al.
Publicado: (2021)

Impact on Mortality of a Bundle for the Management of Enterococcal Bloodstream Infection
por: Bartoletti, Michele, et al.
Publicado: (2019)

Epidemiology of Meropenem/Vaborbactam Resistance in KPC-Producing Klebsiella pneumoniae Causing Bloodstream Infections in Northern Italy, 2018
por: Gaibani, Paolo, et al.
Publicado: (2021)

Antiviral activity of interferon-based combination therapy in critically ill patients with COVID-19: Preliminary observations
por: Gaibani, Paolo, et al.
Publicado: (2021)

Impact of Inflammation on Voriconazole Exposure in Critically ill Patients Affected by Probable COVID-19-Associated Pulmonary Aspergillosis
por: Gatti, Milo, et al.
Publicado: (2023)

Successful Treatment of Bloodstream Infection due to a KPC-Producing Klebsiella Pneumoniae Resistant to Imipenem/Relebactam in a Hematological Patient
por: Gaibani, Paolo, et al.
Publicado: (2022)

Prognostic Utility of the New Definition of Difficult-to-Treat Resistance Among Patients With Gram-Negative Bloodstream Infections
por: Giannella, Maddalena, et al.
Publicado: (2019)

Opportunistic infections in end stage liver disease
por: Bartoletti, Michele, et al.
Publicado: (2018)

Considerations About Antimicrobial Stewardship in Settings with Epidemic Extended-Spectrum β-Lactamase-Producing or Carbapenem-Resistant Enterobacteriaceae
por: Viale, Pierluigi, et al.
Publicado: (2015)

Non-fermentative gram-negative bloodstream infection in northern Italy: a multicenter cohort study
por: Pascale, Renato, et al.
Publicado: (2021)

147. Non-Fermenting Gram-Negative Bloodstream Infection: A Multicenter Retrospective Cohort Study
por: Pascale, Renato, et al.
Publicado: (2019)

Successful Treatment of Bacteremia and Ventilator-Associated Pneumonia Caused by KPC/OXA-48-like Klebsiella pneumoniae Co-Producer with a Continuous Infusion of High-Dose Meropenem Plus Fosfomycin Guided by Real-Time Therapeutic Drug Monitoring
por: Cojutti, Pier Giorgio, et al.
Publicado: (2022)

Relationship Between Immune Response to Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines and Development of Breakthrough Infection in Solid Organ Transplant Recipients: The CONTRAST Cohort
por: Bonazzetti, Cecilia, et al.
Publicado: (2023)

The Gut Microbiota of Critically Ill Patients With COVID-19
por: Gaibani, Paolo, et al.
Publicado: (2021)

Neutralizing monoclonal antibodies for early treatment of hospital‐acquired SARS‐CoV‐2 infection in hematologic patients
por: Bussini, Linda, et al.
Publicado: (2022)

The lower respiratory tract microbiome of critically ill patients with COVID-19
por: Gaibani, Paolo, et al.
Publicado: (2021)

Combined computed tomography and fluorodeoxyglucose positron emission tomography in the diagnosis of prosthetic valve endocarditis: a case series
por: Bartoletti, Michele, et al.
Publicado: (2014)

Pharmacokinetic/Pharmacodynamic Analysis of Continuous-Infusion Fosfomycin in Combination with Extended-Infusion Cefiderocol or Continuous-Infusion Ceftazidime-Avibactam in a Case Series of Difficult-to-Treat Resistant Pseudomonas aeruginosa Bloodstream Infections and/or Hospital-Acquired Pneumonia
por: Gatti, Milo, et al.
Publicado: (2022)

Identify Drug-Resistant Pathogens in Patients with Community-Acquired Pneumonia
por: Amati, Francesco, et al.
Publicado: (2023)

Clinical characteristics, management and health related quality of life in young to middle age adults with COVID-19
por: Temperoni, Chiara, et al.
Publicado: (2021)

A comparative analysis of unintegrated HIV-1 DNA measurement as a potential biomarker of the cellular reservoir in the blood of patients controlling and non-controlling viral replication
por: Orlandi, Chiara, et al.
Publicado: (2020)

Expert clinical pharmacological advice may make an antimicrobial TDM program for emerging candidates more clinically useful in tailoring therapy of critically ill patients
por: Gatti, Milo, et al.
Publicado: (2022)

Preliminary Experience With Low Molecular Weight Heparin Strategy in COVID-19 Patients
por: Paolisso, Pasquale, et al.
Publicado: (2020)

Prevalence of COVID-19-Associated Pulmonary Aspergillosis: Critical Review and Conclusions
por: Egger, Matthias, et al.
Publicado: (2022)

Clinical outcome in solid organ transplant recipients affected by COVID-19 compared to general population: a systematic review and meta-analysis
por: Gatti, Milo, et al.
Publicado: (2022)

Breakthrough invasive fungal infection after liver transplantation in patients on targeted antifungal prophylaxis: A prospective multicentre study
por: Rinaldi, Matteo, et al.
Publicado: (2021)

Relationship between Pharmacokinetic/Pharmacodynamic Target Attainment and Microbiological Outcome in Critically Ill COVID-19 Patients with Documented Gram-Negative Superinfections Treated with TDM-Guided Continuous-Infusion Meropenem
por: Sanz Codina, Maria, et al.
Publicado: (2022)

Critically ill patients with COVID-19 show lung fungal dysbiosis with reduced microbial diversity in patients colonized with Candida spp.
por: Viciani, Elisa, et al.
Publicado: (2022)

Oral Versus Standard Antimicrobial Treatment for Pyogenic Native Vertebral Osteomyelitis: A Single-Center, Retrospective, Propensity Score-Balanced Analysis
por: Marconi, Lorenzo, et al.
Publicado: (2022)

Sixty-Day Mortality Among 520 Italian Hospitalized COVID-19 Patients According to the Adopted Ventilatory Strategy in the Context of an Integrated Multidisciplinary Clinical Organization: A Population-Based Cohort Study
por: Potalivo, Antonella, et al.
Publicado: (2020)

Incidence and Prognosis of Ventilator-Associated Pneumonia in Critically Ill Patients with COVID-19: A Multicenter Study
por: Giacobbe, Daniele Roberto, et al.
Publicado: (2021)

X4 viruses are frequently archived in patients with long-term HIV infection but do not seem to influence the “inflamm-aging” process
por: Saracino, Annalisa, et al.
Publicado: (2013)

Bloodstream infections in the COVID-19 era: results from an Italian multi-centre study
por: Pasquini, Zeno, et al.
Publicado: (2021)

Impact of Maximizing Css/MIC Ratio on Efficacy of Continuous Infusion Meropenem Against Documented Gram-Negative Infections in Critically Ill Patients and Population Pharmacokinetic/Pharmacodynamic Analysis to Support Treatment Optimization
por: Cojutti, Pier Giorgio, et al.
Publicado: (2021)

Colonisation with Extended-Spectrum Cephalosporin-Resistant Enterobacterales and Infection Risk in Surgical Patients: A Systematic Review and Meta-analysis
por: Righi, Elda, et al.
Publicado: (2023)

A Proof of Concept of the Usefulness of a TDM-Guided Strategy for Optimizing Pharmacokinetic/Pharmacodynamic Target of Continuous Infusion Ampicillin-Based Regimens in a Case Series of Patients with Enterococcal Bloodstream Infections and/or Endocarditis
por: Gatti, Milo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ovedpei0fdrolq2bcs897k6hou